Clinical Trials

NCT Number: NCT05828082 Phase: PHASE2 Trial Summary: This phase II trial tests how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and that has a mutation in the gene responsible for making the – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) […]

NCT Number: NCT05803941 Phase: PHASE4 Trial Summary: The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as [177Lu]Lu-PSMA-617 or 17 – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Novartis Pharmaceuticals Acronym:

NCT Number: NCT05733351 Phase: PHASE1 Trial Summary: This phase I trial tests the safety and effectiveness of vudalimab (XmAb20717) in combination with standard of care treatment abiraterone, enzalutamide, or abiraterone plus docetaxel in treating patie – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Emory University Acronym:

NCT Number: NCT05689021 Phase: Trial Summary: This phase II trial tests how well abiraterone acetate/niraparib (CJNJ-67652000 [niraparib/abiraterone acetate fixed-dose combination]) and prednisone works in treating patients with castration-resi – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic Acronym:

NCT Number: NCT05851365 Phase: Trial Summary: This is a single site, prospective pilot study to determine the feasibility and safety of the administration of HP 13C bicarbonate in 10 patients with prostate cancer to determine potential hydrogen ( – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): Robert Flavell, MD, PhD Acronym:

NCT Number: NCT00034216 Phase: Trial Summary: This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and ol – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym:

NCT Number: NCT00451022 Phase: Trial Summary: This study aims to provide long-term follow-up care of patients previously enrolled in a vaccine study that involved poxviral vectors. Vectors are sequences of genetic material that can be used to int – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym:

NCT Number: NCT02594202 Phase: Trial Summary: Background: Prostate cancer is the most common noncutaneous cancer among men in the U.S. Researchers want to study blood, tissue, and fluid samples of people with prostate cancer. This will help them – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym:

NCT Number: NCT03354416 Phase: Trial Summary: Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therap – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): National Cancer […]

NCT Number: NCT04314401 Phase: Trial Summary: This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The “Cancer Moonshot Biobank” is a longitudinal study. This means it collects and stores sa – clinicaltrials.gov for more information and location Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym: